已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Faculty Opinions recommendation of Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.

医学 入射(几何) 内科学 病因学 置信区间 肝移植 肝损伤 人口 中国大陆 儿科 中国 移植 环境卫生 光学 物理 政治学 法学
作者
Bruno Stieger
出处
期刊:
标识
DOI:10.3410/f.735070178.793562947
摘要

BACKGROUND & AIMS: We performed a nationwide, retrospective study to determine the incidence and causes of drug-induced liver injury (DILI) in mainland China.METHODS: We collected data on a total of 25,927 confirmed DILI cases, hospitalized from 2012 through 2014 at 308 medical centers in mainland China. We collected demographic, medical history, treatment, laboratory, disease severity, and mortality data from all patients. Investigators at each site were asked to complete causality assessments for each case whose diagnosis at discharge was DILI (n = 29,478) according to the Roussel Uclaf Causality Assessment Method.RESULTS: Most cases of DILI presented with hepatocellular injury (51.39%; 95% confidence interval [CI] 50.76-52.03), followed by mixed injury (28.30%; 95% CI 27.73-28.87) and cholestatic injury (20.31%; 95% CI 19.80-20.82). The leading single classes of implicated drugs were traditional Chinese medicines or herbal and dietary supplements (26.81%) and antituberculosis medications (21.99%). Chronic DILI occurred in 13.00% of the cases and, although 44.40% of the hepatocellular DILI cases fulfilled Hy's Law criteria, only 280 cases (1.08%) progressed to hepatic failure, 2 cases underwent liver transplantation (0.01%), and 102 patients died (0.39%). Among deaths, DILI was judged to have a primary role in 72 (70.59%), a contributory role in 21 (20.59%), and no role in 9 (8.82%). Assuming the proportion of DILI in the entire hospitalized population of China was represented by that observed in the 66 centers where DILI capture was complete, we estimated the annual incidence in the general population to be 23.80 per 100,000 persons (95% CI 20.86-26.74). Only hospitalized patients were included in this analysis, so the true incidence is likely to be higher.CONCLUSIONS: In a retrospective study to determine the incidence and causes of DILI in mainland China, the annual incidence in the general population was estimated to be 23.80 per 100,000 persons; higher than that reported from Western countries. Traditional Chinese medicines, herbal and dietary supplements, and antituberculosis drugs were the leading causes of DILI in mainland China.Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved. PMID: 30742832 Funding information This work was supported by: Medical Research Council, United Kingdom Grant ID: MR/N005953/1

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
神通广大的MOMO完成签到,获得积分10
1秒前
英俊的铭应助随机的昵称采纳,获得10
2秒前
2秒前
szd007完成签到,获得积分10
2秒前
耶果完成签到 ,获得积分10
4秒前
Nole应助Yy采纳,获得10
4秒前
5秒前
CodeCraft应助huangjiawei采纳,获得10
6秒前
JamesPei应助俊逸寻雪采纳,获得10
7秒前
8秒前
小蘑菇应助成就的冰双采纳,获得10
8秒前
jianinghehe完成签到,获得积分10
9秒前
molihuakai应助大力迎曼采纳,获得10
10秒前
11秒前
林间月完成签到,获得积分10
12秒前
13秒前
drtftyv发布了新的文献求助30
13秒前
谨慎石头发布了新的文献求助10
14秒前
Akim应助淡然的依琴采纳,获得10
14秒前
ling完成签到 ,获得积分10
15秒前
薛点点发布了新的文献求助10
15秒前
Nuyoah完成签到 ,获得积分10
15秒前
lvcha完成签到 ,获得积分10
15秒前
allshestar完成签到 ,获得积分0
17秒前
踏实的冥王星完成签到,获得积分10
19秒前
20秒前
超级小蝴蝶完成签到 ,获得积分10
21秒前
研友_LmbRgn完成签到 ,获得积分10
23秒前
小蝶完成签到,获得积分10
24秒前
25秒前
26秒前
思源应助科研通管家采纳,获得10
26秒前
orixero应助科研通管家采纳,获得10
26秒前
西哥完成签到,获得积分10
26秒前
DW应助科研通管家采纳,获得10
27秒前
隐形曼青应助科研通管家采纳,获得10
27秒前
27秒前
CipherSage应助科研通管家采纳,获得10
27秒前
无极微光应助科研通管家采纳,获得20
27秒前
脑洞疼应助科研通管家采纳,获得10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
A Case Study on Hotels as Noncongregate Emergency Living Accommodations for Returning Citizens 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7765245
求助须知:如何正确求助?哪些是违规求助? 9309548
关于积分的说明 20311504
捐赠科研通 7350031
什么是DOI,文献DOI怎么找? 3314756
关于科研通互助平台的介绍 2464155
邀请新用户注册赠送积分活动 2329211